Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GH · against 596 other Healthcare companies listed in US-listed
Ranked #545 of 597 · scores higher than 9% of peers · safety percentile 5
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)95 peers with a safety percentile of 0–9, including GH · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | GH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | Not reported | 0.23× | — | — | 33% |
| BetaLower is better · 556 reported | 1.58 | 0.95 | 21% | 33% | |
| Current ratioHigher is better · 600 reported | 4.03× | 3.91× | 50% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 541 | 8.8B USD | 6 | 31 | |
| 542 | 7.3B USD | 6 | 32 | |
| 543 | 48.9B USD | 5 | 54 | |
| 544 | 296M USD | 5 | 66 | |
| 545 | 23.5B USD | 5 | 27 | |
| 546 | 1.7B USD | 5 | 31 | |
| 547 | 423M USD | 5 | 29 | |
| 548 | 1.2B USD | 5 | 39 | |
| 549 | 14.5B USD | 5 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score